| Financial Year |
March 31 2023 |
| Monetary Funds |
51,779,196.31 |
| Held-for-trading Financial Assets |
21,977.80 |
| Notes Receivable |
203,145,288.39 |
| Accounts Receivable |
364,068,675.02 |
| Advances to Suppliers |
123,671,874.88 |
| Other Receivables |
14,252,813.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
614,384,536.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
39,547,579.04 |
| Total Current Assets |
1,503,665,991.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
64,922,794.75 |
| Fixed Assetes |
103,147,255.66 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
23,123,720.34 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
276,705.11 |
| Deferred Income Tax Assets |
32,916,645.50 |
| Other Non-Current Assets |
127,046,444.40 |
| Sub-Total of Non-Current Assets |
372,933,565.76 |
| Total Assets |
1,876,599,557.57 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
49,955,956.80 |
| Accounts Payable |
225,355,833.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,532,825.55 |
| Taxes Payable |
6,357,150.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,464,336.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
110,510,862.89 |
| Sub-Total of Current Liabilities |
937,367,762.85 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
5,500,000.00 |
| Sub-Total of Non-Current Liabilities |
19,399,246.15 |
| Total Liabilities |
956,767,009.00 |
| Paid-In Capital(Or Share Stock) |
223,645,500.00 |
| Capital Surplus |
206,900,507.76 |
| Surplus Reserve |
68,702,394.64 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
384,637,118.66 |
| Minority Stockholder's Interest |
35,947,027.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
883,885,521.06 |
| Owner's Equity（Stockholder's Equity） |
919,832,548.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,876,599,557.57 |
